Setoxaximab Biosimilar - Anti-Stx2, SLT-II mAb - Research Grade
Source
CAS 1351470-17-1
Species
Chimeric
Expression system
Mammalian cells
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Setoxaximab,Shigamabs-(drug name for the combination of pritoxaximab and setoxaximab),caStx2,Stx2, SLT-II,anti-Stx2, SLT-II
Reference
PX-TA1319
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
IgG1-kappa
Clonality
Monoclonal Antibody
Description of Setoxaximab Biosimilar - Anti-Stx2, SLT-II mAb - Research Grade
General information on Anti-Stx2/SLT-II[Escherichia coli] (Setoxaximab) Monoclonal Antibody
Setoxaximab has been investigated for the prevention and treatment of Shiga-like toxin-producing Escherichia coli(STEC) or E. coli serotype O121 infection.
Reviews
There are no reviews yet.